Cargando…
Dopaminergic medication impairs feedback-based stimulus-response learning but not response selection in Parkinson's disease
Cognitive dysfunction is a feature of Parkinson's Disease (PD). Some cognitive functions are impaired by dopaminergic medications prescribed to address the movement symptoms that typify PD. Learning appears to be the cognitive function most frequently worsened by dopaminergic therapy. However,...
Autores principales: | Vo, Andrew, Hiebert, Nole M., Seergobin, Ken N., Solcz, Stephanie, Partridge, Allison, MacDonald, Penny A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4183099/ https://www.ncbi.nlm.nih.gov/pubmed/25324767 http://dx.doi.org/10.3389/fnhum.2014.00784 |
Ejemplares similares
-
Dopaminergic therapy affects learning and impulsivity in Parkinson’s disease
por: Hiebert, Nole M, et al.
Publicado: (2014) -
Pramipexole Impairs Stimulus-Response Learning in Healthy Young Adults
por: Gallant, Haley, et al.
Publicado: (2016) -
Striatum-Mediated Deficits in Stimulus-Response Learning and Decision-Making in OCD
por: Hiebert, Nole M., et al.
Publicado: (2020) -
Biomarkers of Parkinson's disease: Striatal sub-regional structural morphometry and diffusion MRI
por: Khan, Ali R., et al.
Publicado: (2018) -
Dopaminergic Therapy Increases Go Timeouts in the Go/No-Go Task in Patients with Parkinson’s Disease
por: Yang, Xue Q., et al.
Publicado: (2018)